- Home
- IPSC vs TACT Comparison
IPSC vs TACT Comparison
Compare IPSC & TACT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPSC
- TACT
- Stock Information
- Founded
- IPSC 2019
- TACT 1996
- Country
- IPSC United States
- TACT United States
- Employees
- IPSC N/A
- TACT N/A
- Industry
- IPSC Medicinal Chemicals and Botanical Products
- TACT Computer peripheral equipment
- Sector
- IPSC Health Care
- TACT Technology
- Exchange
- IPSC Nasdaq
- TACT Nasdaq
- Market Cap
- IPSC 43.6M
- TACT 42.2M
- IPO Year
- IPSC 2021
- TACT 1996
- Fundamental
- Price
- IPSC $0.50
- TACT $4.58
- Analyst Decision
- IPSC Strong Buy
- TACT Strong Buy
- Analyst Count
- IPSC 5
- TACT 1
- Target Price
- IPSC $3.33
- TACT $5.00
- AVG Volume (30 Days)
- IPSC 603.4K
- TACT 68.6K
- Earning Date
- IPSC 11-04-2025
- TACT 11-06-2025
- Dividend Yield
- IPSC N/A
- TACT N/A
- EPS Growth
- IPSC N/A
- TACT N/A
- EPS
- IPSC N/A
- TACT N/A
- Revenue
- IPSC $114,128,000.00
- TACT $47,949,000.00
- Revenue This Year
- IPSC $1,589.94
- TACT $21.67
- Revenue Next Year
- IPSC N/A
- TACT $7.63
- P/E Ratio
- IPSC N/A
- TACT N/A
- Revenue Growth
- IPSC 5491.77
- TACT N/A
- 52 Week Low
- IPSC $0.34
- TACT $3.12
- 52 Week High
- IPSC $1.86
- TACT $4.89
- Technical
- Relative Strength Index (RSI)
- IPSC 43.47
- TACT 62.89
- Support Level
- IPSC $0.46
- TACT $4.09
- Resistance Level
- IPSC $0.52
- TACT $4.76
- Average True Range (ATR)
- IPSC 0.03
- TACT 0.18
- MACD
- IPSC 0.00
- TACT -0.00
- Stochastic Oscillator
- IPSC 41.33
- TACT 73.13
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.
About TACT TransAct Technologies Incorporated
Transact Technologies Inc develops and sells software-driven technology and printing solutions. The company's software is sold under BOHA, AccuDate, Epic, EPICENTRAL, Ithaca, and Printrex brand names. It also provides supplies and consumables used in the printing and scanning activities to restaurant and hospitality, banking, retail, casino and gaming, point of sale automation, lottery, medical, mobile, oil, and gas markets. Majority of the revenue is derived from the casinos and gaming industry followed by the Foodservice technology market. Its geographical segments are the United States and International, of which the majority of its revenue comes from the United States.